During the past decade, Stanford Cancer Center South Bay conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 7 clinical trials were completed, i.e. on average, 38.9% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 7 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stanford Cancer Center South Bay" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "NRG Oncology" with 6 trials sponsored, "Stanford University" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "Polyphor Ltd." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stanford Cancer Center South Bay" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "Genmab" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Stanford Cancer Center South Bay" are "Invasive Breast Carcinoma" (2 trials), "Triple-Negative Breast Carcinoma" (2 trials), "Abdominoplasty" (1 trials), "Acute Myeloid Leukemia" (1 trials) and "Advanced Head and Neck Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "Stanford Cancer Center South Bay" in a lesser frequency.

Most popular intervention types in "Stanford Cancer Center South Bay" are "Drug" (16 trials), "Other" (12 trials), "Biological" (7 trials), "Radiation" (7 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (7 trials), "Laboratory Biomarker Analysis" (6 trials), "Questionnaire Administration" (5 trials), "Cisplatin" (4 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Stanford Cancer Center South Bay" are 17 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Stanford Cancer Center South Bay". undefined are not yet recruiting, 5 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Stanford Cancer Center South Bay, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Stanford Cancer Center South Bay, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".